213 related articles for article (PubMed ID: 29987901)
1. Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois.
Ogasawara N; Klingler AI; Tan BK; Poposki JA; Hulse KE; Stevens WW; Peters AT; Grammer LC; Welch KC; Smith SS; Conley DB; Kern RC; Schleimer RP; Kato A
Allergy; 2018 Nov; 73(11):2251-2254. PubMed ID: 29987901
[No Abstract] [Full Text] [Related]
2. Differentiating osteomeatal complex disease and chronic rhinosinusitis from nonallergic rhinitis.
Baraniuk JN; Casado B; Malekzadeh S
Clin Allergy Immunol; 2007; 19():115-46. PubMed ID: 17153011
[No Abstract] [Full Text] [Related]
3. Expression of IL-25, IL-33, and Thymic Stromal Lymphopoietin in Nasal Polyp Gland Duct Epithelium in Patients With Chronic Rhinosinusitis.
Nagata Y; Maruoka S; Gon Y; Mizumura K; Kishi H; Nomura Y; Hikichi M; Hashimoto S; Oshima T
Am J Rhinol Allergy; 2019 Jul; 33(4):378-387. PubMed ID: 30873846
[No Abstract] [Full Text] [Related]
4. The activation and function of IL-36γ in neutrophilic inflammation in chronic rhinosinusitis.
Wang H; Li ZY; Jiang WX; Liao B; Zhai GT; Wang N; Zhen Z; Ruan JW; Long XB; Wang H; Liu WH; Liang GT; Xu WM; Kato A; Liu Z
J Allergy Clin Immunol; 2018 May; 141(5):1646-1658. PubMed ID: 29274415
[TBL] [Abstract][Full Text] [Related]
5. Chronic rhinosinusitis with nasal polyps is associated with impaired TMEM16A-mediated epithelial chloride secretion.
Salomon JJ; Albrecht T; Graeber SY; Scheuermann H; Butz S; Schatterny J; Mairbäurl H; Baumann I; Mall MA
J Allergy Clin Immunol; 2021 Jun; 147(6):2191-2201.e2. PubMed ID: 33609628
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Systematic Review of the Association Between Airway Mucins and Chronic Rhinosinusitis.
Kato K; Song BH; Howe CL; Chang EH
Am J Rhinol Allergy; 2019 Jul; 33(4):433-448. PubMed ID: 30892914
[No Abstract] [Full Text] [Related]
7. Alcohol hyper-responsiveness in chronic rhinosinusitis with nasal polyps.
De Schryver E; Derycke L; Campo P; Gabriels E; Joos GF; Van Zele T; Bachert C; Hellings PW; Gevaert P
Clin Exp Allergy; 2017 Feb; 47(2):245-253. PubMed ID: 27770460
[TBL] [Abstract][Full Text] [Related]
8. Epithelial dysregulation in chronic rhinosinusitis with nasal polyposis (CRSwNP) and aspirin-exacerbated respiratory disease (AERD).
Kohanski MA; Cohen NA; Barrett NA
J Allergy Clin Immunol; 2021 Nov; 148(5):1161-1164. PubMed ID: 34371082
[No Abstract] [Full Text] [Related]
9. CD8(+) T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.
Ma J; Shi LL; Deng YK; Wang H; Cao PP; Long XB; Zhang XH; Liu Y; Zeng M; Liu Z
Clin Exp Allergy; 2016 Sep; 46(9):1162-75. PubMed ID: 27176491
[TBL] [Abstract][Full Text] [Related]
10. Increased activation and differentiated localization of native and phosphorylated STAT3 in nasal polyps.
Linke R; Pries R; Könnecke M; Bruchhage KL; Böscke R; Gebhard M; Wollenberg B
Int Arch Allergy Immunol; 2013; 162(4):290-8. PubMed ID: 24157808
[TBL] [Abstract][Full Text] [Related]
11. Formation of papillary mucosa folds and enhancement of epithelial barrier in odontogenic sinusitis.
Zhang Y; Lan F; Li Y; Wang C; Zhang L
Int Forum Allergy Rhinol; 2019 Nov; 9(11):1281-1288. PubMed ID: 30620087
[TBL] [Abstract][Full Text] [Related]
12. The tumor necrosis factor family molecules LIGHT and lymphotoxins in sinus mucosa of patients with chronic rhinosinusitis with or without nasal polyps.
Hwang JW; Kim YC; Lee HY; Lee KJ; Kim TH; Lee SH
Cytokine; 2021 Dec; 148():155594. PubMed ID: 34083106
[TBL] [Abstract][Full Text] [Related]
13. Differences in the distribution of CD20, CD3, CD34 and CD45RO in nasal mucosa and polyps from patients with chronic rhinosinusitis.
Mitroi M; Albulescu D; Capitanescu A; Docea AO; Musat G; Mitroi G; Zlatian O; Tsatsakis A; Tzanakakis G; Spandidos DA; Calina D
Mol Med Rep; 2019 Apr; 19(4):2792-2800. PubMed ID: 30720103
[TBL] [Abstract][Full Text] [Related]
14. Relationship of TLR2, TLR4 and tissue remodeling in chronic rhinosinusitis.
Wang X; Zhao C; Ji W; Xu Y; Guo H
Int J Clin Exp Pathol; 2015; 8(2):1199-212. PubMed ID: 25973005
[TBL] [Abstract][Full Text] [Related]
15. Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.
Takabayashi T; Schleimer RP
J Allergy Clin Immunol; 2020 Mar; 145(3):740-750. PubMed ID: 32145873
[TBL] [Abstract][Full Text] [Related]
16. The role of superantigens in chronic rhinosinusitis with nasal polyps.
Wang M; Shi P; Chen B; Zhang H; Jian J; Chen X; Wang Z; Zhang D
ORL J Otorhinolaryngol Relat Spec; 2008; 70(2):97-103. PubMed ID: 18408407
[TBL] [Abstract][Full Text] [Related]
17. Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbumin.
Kim HC; Lim JY; Kim S; Kim JH; Jang YJ
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3899-3906. PubMed ID: 28828551
[TBL] [Abstract][Full Text] [Related]
18. Role of IFN-γ, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps.
Jiao J; Duan S; Meng N; Li Y; Fan E; Zhang L
Clin Exp Allergy; 2016 Mar; 46(3):449-60. PubMed ID: 26399381
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17A-induced inflammation does not influence the development of nasal polyps in murine model.
Hong SL; Zhang YL; Kim SW; Kim DW; Cho SH; Chang YS; Lee CH; Rhee CS
Int Forum Allergy Rhinol; 2015 May; 5(5):363-70. PubMed ID: 25754984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
